We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novartis, Intellia Therapeutics and Caribou Biosciences Collaborate

News   Jan 07, 2015

 
Novartis, Intellia Therapeutics and Caribou Biosciences Collaborate
 
 
Advertisement
 

RELATED ARTICLES

Common Genetic Variant Identified As Frequent Cause of Deafness

News

A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research.

READ MORE

A Watched Pot Never Boils… But That’s Not the Case With DNA

News

Liquid droplets formed from DNA display a peculiar response to enzymes. An international collaboration has now been able to explain the mechanisms behind bubble formation.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE